Calculate the infusion time for an IV of 1,500 mL running at 25 gtt/min. if the drop factor is 15 gtt/mL.

A. Headache, dizziness, and fatigue

Ondansetron (Zofran) is commonly used to control nausea and vomiting associated with chemotherapy. While it is generally well-tolerated, some common side effects may include headache, dizziness, and fatigue.

B. Anorexia and hair loss

Anorexia (loss of appetite) and hair loss are not commonly associated with ondansetron. These symptoms may be side effects of chemotherapy itself, but they are not typically attributed to ondansetron.

C. Abdominal cramping and irritability

Abdominal cramping and irritability are not common side effects of ondansetron. These symptoms may be related to other factors, but they are not typically associated with this antiemetic medication.

D. Psychosis and middle ear disturbances

Psychosis and middle ear disturbances are not common side effects of ondansetron. These symptoms may be associated with other medications or conditions, but they are not typically attributed to ondansetron.

A. The patient's understanding of the medication:

While it's important for the patient to understand their medication, assessing their understanding is typically done through patient education and counseling. This assessment is vital for promoting adherence and safe medication practices but is not the primary consideration immediately before administration.

B. The patient's ability to swallow:

This is the correct answer. Assessing the patient's ability to swallow is crucial before administering oral medications to ensure that the patient can safely and effectively take the prescribed medication without the risk of aspiration or choking.

C. The patient's allergies:

Assessing the patient's allergies is an essential step in medication administration, but it is generally part of the overall medication safety process. It may not be the primary assessment immediately before administering an oral medication, but it is a crucial consideration.

D. The eyesight:

The patient's eyesight is not typically a primary assessment before administering oral medications. While visual impairments can affect a patient's ability to read medication labels or instructions, it is not the immediate concern when assessing readiness for oral medication administration.